Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Vra5g0402 | ATGGCGTTTGAGCAAACCTCTGTTCCTGGCGGCGATGTTGTGCGGCCACTGAATTCAGTAGCTCGGAGTGTGGCGGAAGAGTCTCTCGTTTTGCCGGTATCTACGGCGGTTCCTGGCGCGCTGCCGATTTTCTATCCTGCGTCTGTCTCTGATGCTGGCTTGGTTGGAATGGGGTATGGGAATGTGACTTCGGGAGGTGGCGGTGGTGCTGCCACGTGGTGTGTGCGCCCCGCTGTGCCAGTTCATAATCACAATCCCTCTGTGAATCCTGCTGTTGGATTTGTTCATGCTCCTAGTTTTCCCAATAGAGTTGGTGCTGTAGGTGGCAATGCTGTTGATGTTTCAAGTAGTTTTGTGGCTGCTACTCATGGGTTTCCTATGAATTTGGGGGGTAACTGGGTTGCATCGGGTAATGGCCTAGATAGTATTAATAGTAGTGATGTTAATAATAATAATAATAATAATAATAATAATAATAATAATAATTACAACAACAATGCTGTTCCGGGGAACAGCAGAGTCATTAGCAATTCTGGTGATCATGTGTGTAGTATTGGGGTTGGGTCCATTTCCAATACACCTTCAAGCCAGCGGACAGATCAGGCGATTGAGGAGGGTGGGGATGATTCAATTTCAGGGCGGAAAATGAAGTTGATGTGCAGTTATGGTGGGAAGATTTTGCCTAGGCCTAGTGATGGGATGTTGAGATATGTTGGAGGGCAGACAAGGATCATAAGTGTTAAGAGAGATGTGAGTTTTAATGATTTGGTGCAGAAGATGGTTAGTACATTTGGGCAGCATGTGGTTATCAAATATCAGCTCCCTGATGAGGATCTGGATGCATTGGTTTCGGTTTCCTGCCCTGATGATCTGGAGAATATGATGGAGGAGTATGAGAGGTTGATTGAGAGGTCTCCTGACGGTTCTCCCAAGTTAAGGGTCTTTCTTCTTTCTTCTTCAGAACTCGATCCTTCTGGTGTAGCACAGTTTGTAAATTTGCATGATGGTGGACTGAAATATGTTGAAGCTGTGAATGGAATTGCTGATGGGATTGGTGGCAAACTAACAAGGAAAGCGAGCTATACAAGCGCAGTATCTACTCAGAATTCTGATTTTAGCGGGATAGATGCTCTTGATAGCTTGAATGCTGCTCAAGGGGATGTCAGAGGGGATGTCAGTGGGGTACCTGTACCTATGCCCAGTTCTTTATCACCTGAGGGGAACGTGGCTGCTTCTCATGATGGTACCTTAAATTCTGTGGTTCCTGAGCCTGGTACATCTTACACAGAGGCCTCTGCGGTTCCACCGGGCATTCCTGTAACAAATTATGGTCCAACTCACATTCCACCTCTCCAGAATGAGGTTGAGTTAGAAAAGTCTGTACCTGTTACTTTTTCTCAGACTCAATTTGGGTTACAACAATCTGGTTTGGAAATTCCACCTTCTACACCTTTGCAAACTTCTTTTGATCATCGCCAGGAGGTTATGAACCATGTTGATTATGTCCAGCTTCCTCCCCATATGGGATTCCTGAATCCTCAATTTCTAGGTAAGCCTGGATCCATCTACTCCCAACATCAATTTCATGATAATACTTCTCGTTTTGGGTCCCATCAGGTAATCCCTGCAGTGCAAATGACCATGACTCAGCCATTTTCTCATGCTGCTTTAAGACCCAGTGTTATTCAACCACAAGCATTCATGCAACCTCAGCAAAACCGTTTGGACCAATATAATGATGAAAATGCTTCAGGGCTAAGGATTCACCAGGTTCCTGCTGAACAAAGTTACAACACATTTCAGGTTCAAGTCCCTTTTGGAGGTAATTATGGCTGGGTCCAGGTTCCTTCTGCAGACCATGTGATCTTTTCTGATGCATTTGTACCTCAACAACCAATGATGATCCCTGAGAAACTCCAACGAGTGGAGGACTGTTATATGTGTCAGAAAAAGCTGCCTCATGCACATTCAGATCCTGTGGTTCAGGATCAGCGAAATAGCTGTGCTGGTCCAATTTCTGATTCAATCCAAAGTTTCTATAGTCTCCCTACGGAGGACAATTCTAGGGCTCAAGCAACAAATATGGTTTTGGTGTCTGCACCAATGAAGGATGACAATGTTGAACAAGTAGTTGTGACAAGACCCAAGGTCTTTAGCAAATTGGATACTCCAGCTGGAGCAGCTTGTACAGACACAGCTGGTCTTTCTCTGGAGCTTGAAAGTGAGACGGCTTTTATACAAAAGCTGGACAGGTCTGATCATCCCAGGAATGCAGTTATCCAGGAAGCTGTTGTAAGAACAGGAGAAAAACAGTTGCCAAGTGATGGGCTGGTAGCACCGCATTCTTATCGTGATGATATCACCCGCCAGCATATGGTGCCACTTGATAGCAGGTCTAAAGAGGATGCTCTTGTGAATAAACCTGTTACTAATGATATACCTTTAGTTGGTGGCACATCTGTTGAAAATTCTGACTGTATGGTTCAAGAGTGTCCAACAGAATATACAAATGAACTTTGTAGCACTACTTCAAAAGCAGATGCCATGGAGAATTGGATAGCACAAGATCTTCTCAAACCTATTGATGGAAGAATAGACAACCTGAAAATAGGTAATCCTGAAAATTTTCTAAATAATGATAAATTTGATTACAGCACTCAACATGTTGCAGAGAAGAAAGGGGTCCCTCTAGATAACAATATTGGGAAGTCAAAGTTGATCACTGATGCTGATCAAATTAATATGGTAGATTTGCTTCCTAGTTCTACTGTGGAAATTTCATATGGGAATAATTCCAGGCCAGTGGAATATAATGAGGTTATACAAACCCCTGTTTGGGGCATACCTGGATCAAATCCTCAGCCAAAGAGTGGAAACCATCACGGGGAGGATGCAGTTTTATCTTCAGTTCCTCCATCTGCTAGATTTGGAGAGGTGAAGGATTCTTCAAACTCACTTTTTAGCAATCAAGATCTATGGAATATACACAGTTCATACTTTCCACCTCCGAGACCTAACAAAGTTACATTGAAGAAAGAAACCTATTCAAATAAGGATCAAGTTGGTGAGAATCTTGGCATCAATGGGGAACAAAATCTGGAAGCTCAAATAGAGAATGGCCTCTATCAAACACTCCAACAGAATTTAACTTTCGAAGAAGCTCGATCTGTCGCCAAGGTCTCATCAGAAGACCGACAACTTCAAGCCGTTGCTGAAGGTTTAGCTGCTTCCGTTCTGCACTCAAGCACTTCTTCAAATCTTGATTTGAATGTCAAAGATGTGTCCCATCACGAGGACATTGGCGATGGAGATGTTCAAAATAATCTAATAGATATACAGCATAAAGATAAAATTCAGGATCTCAAAAACAAGCTCCCAGAGAAATTAAATTTTGGCTTTCCAGCATCAGATGTTGGAGCTTTGCAGATTATAAAAAATTGTGACCTTGAAGAGCTGATAGAGTTGGGTTCTGGGACCTTTGGGACTGTATATCATGGAAAATGGAGGGGCAGTGATGTGGCAATAAAGCGGATTAATGATAGGTGTTTTGCAGGAAAGCATTCGGAGCAAGAGCGCCTGAGAGCAGACTTTTGGAATGAGGCAATCAAGCTTGCTGACTTGCATCATCCAAATGTGGTAGCATTCTATGGTGTTGTGCTTGATGGCCCCGGAGGTTCTGTGGCAACAGTGACGGAGTATATGGTAAATGGTTCTCTAAGAAATGCGTTGCAGAAGAATGGGAGGAATCTTGACAAGCGCAAGCGGCTGTTGATTGCGATGGATGTGGCCTTTGGCATGGAGTACTTGCATGGAAAAAATATAGTACACTTTGACTTGAAAAGTGACAACTTGCTCGTGAATCTCCGAGATCCACATCGTCCGATATGCAAGGTTGGTGATTTGGGTCTGTCCAAAGTGAAATGCCAGACTTTAATATCCGGCGGAGTTAGAGGAACTCTACCTTGGATGGCCCCAGAACTGCTGAATGGGAGCAGTAGTCTTGTATCAGAGAAGGTTGATGTGTTTTCGTTTGGTATTGTTATGTGGGAACTGCTCACGGGAGAAGAGCCGTATGCTGATTTGCACTATGGGGCCATTATAGGTGGTATAGTAAACAACACTTTAAGACCTCCAGTTCCAGAATCTTGCGATCCAGAATGGAGACTGCTAATGGAGATGTGCTGGTCATCCGAACCATCAGAAAGACCTTCCTTCACTGAGATTGCCAATGGATTACGTTCCATGGCAACCAAGATTTCTCCGAAAGGACAAAATCAACAGCAGCAACCCGCCTCATCTCTGAGTCAAGCACAGAAATAA | 4320 | 0.437 | MAFEQTSVPGGDVVRPLNSVARSVAEESLVLPVSTAVPGALPIFYPASVSDAGLVGMGYGNVTSGGGGGAATWCVRPAVPVHNHNPSVNPAVGFVHAPSFPNRVGAVGGNAVDVSSSFVAATHGFPMNLGGNWVASGNGLDSINSSDVNNNNNNNNNNNNNNYNNNAVPGNSRVISNSGDHVCSIGVGSISNTPSSQRTDQAIEEGGDDSISGRKMKLMCSYGGKILPRPSDGMLRYVGGQTRIISVKRDVSFNDLVQKMVSTFGQHVVIKYQLPDEDLDALVSVSCPDDLENMMEEYERLIERSPDGSPKLRVFLLSSSELDPSGVAQFVNLHDGGLKYVEAVNGIADGIGGKLTRKASYTSAVSTQNSDFSGIDALDSLNAAQGDVRGDVSGVPVPMPSSLSPEGNVAASHDGTLNSVVPEPGTSYTEASAVPPGIPVTNYGPTHIPPLQNEVELEKSVPVTFSQTQFGLQQSGLEIPPSTPLQTSFDHRQEVMNHVDYVQLPPHMGFLNPQFLGKPGSIYSQHQFHDNTSRFGSHQVIPAVQMTMTQPFSHAALRPSVIQPQAFMQPQQNRLDQYNDENASGLRIHQVPAEQSYNTFQVQVPFGGNYGWVQVPSADHVIFSDAFVPQQPMMIPEKLQRVEDCYMCQKKLPHAHSDPVVQDQRNSCAGPISDSIQSFYSLPTEDNSRAQATNMVLVSAPMKDDNVEQVVVTRPKVFSKLDTPAGAACTDTAGLSLELESETAFIQKLDRSDHPRNAVIQEAVVRTGEKQLPSDGLVAPHSYRDDITRQHMVPLDSRSKEDALVNKPVTNDIPLVGGTSVENSDCMVQECPTEYTNELCSTTSKADAMENWIAQDLLKPIDGRIDNLKIGNPENFLNNDKFDYSTQHVAEKKGVPLDNNIGKSKLITDADQINMVDLLPSSTVEISYGNNSRPVEYNEVIQTPVWGIPGSNPQPKSGNHHGEDAVLSSVPPSARFGEVKDSSNSLFSNQDLWNIHSSYFPPPRPNKVTLKKETYSNKDQVGENLGINGEQNLEAQIENGLYQTLQQNLTFEEARSVAKVSSEDRQLQAVAEGLAASVLHSSTSSNLDLNVKDVSHHEDIGDGDVQNNLIDIQHKDKIQDLKNKLPEKLNFGFPASDVGALQIIKNCDLEELIELGSGTFGTVYHGKWRGSDVAIKRINDRCFAGKHSEQERLRADFWNEAIKLADLHHPNVVAFYGVVLDGPGGSVATVTEYMVNGSLRNALQKNGRNLDKRKRLLIAMDVAFGMEYLHGKNIVHFDLKSDNLLVNLRDPHRPICKVGDLGLSKVKCQTLISGGVRGTLPWMAPELLNGSSSLVSEKVDVFSFGIVMWELLTGEEPYADLHYGAIIGGIVNNTLRPPVPESCDPEWRLLMEMCWSSEPSERPSFTEIANGLRSMATKISPKGQNQQQQPASSLSQAQK* | 1440 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Vra5g0402 | 1439 | MobiDBLite | consensus disorder prediction | 188 | 208 | - | - | |
Vra5g0402 | 1439 | PANTHER | SERINE-THREONINE PROTEIN KINASE | 183 | 962 | - | - | |
Vra5g0402 | 1439 | PANTHER | SERINE-THREONINE PROTEIN KINASE | 979 | 1419 | - | - | |
Vra5g0402 | 1439 | SUPERFAMILY | Protein kinase-like (PK-like) | 1144 | 1410 | IPR011009 | - | |
Vra5g0402 | 1439 | ProSitePatterns | Protein kinases ATP-binding region signature. | 1155 | 1186 | IPR017441 | GO:0005524 | |
Vra5g0402 | 1439 | MobiDBLite | consensus disorder prediction | 144 | 171 | - | - | |
Vra5g0402 | 1439 | Gene3D | Transferase(Phosphotransferase) domain 1 | 1237 | 1439 | - | - | |
Vra5g0402 | 1439 | Gene3D | - | 236 | 319 | - | - | |
Vra5g0402 | 1439 | Gene3D | Phosphorylase Kinase; domain 1 | 1143 | 1236 | - | - | |
Vra5g0402 | 1439 | PRINTS | Tyrosine kinase catalytic domain signature | 1231 | 1244 | IPR001245 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | PRINTS | Tyrosine kinase catalytic domain signature | 1268 | 1286 | IPR001245 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | PRINTS | Tyrosine kinase catalytic domain signature | 1339 | 1361 | IPR001245 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | PRINTS | Tyrosine kinase catalytic domain signature | 1383 | 1405 | IPR001245 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | ProSiteProfiles | Protein kinase domain profile. | 1149 | 1416 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 | |
Vra5g0402 | 1439 | SUPERFAMILY | CAD & PB1 domains | 231 | 322 | - | - | |
Vra5g0402 | 1439 | Pfam | PB1 domain | 235 | 315 | IPR000270 | GO:0005515 | |
Vra5g0402 | 1439 | PANTHER | KINASE SUPERFAMILY WITH OCTICOSAPEPTIDE/PHOX/BEM1P DOMAIN-CONTAINING PROTEIN | 979 | 1419 | - | - | |
Vra5g0402 | 1439 | PANTHER | KINASE SUPERFAMILY WITH OCTICOSAPEPTIDE/PHOX/BEM1P DOMAIN-CONTAINING PROTEIN | 183 | 962 | - | - | |
Vra5g0402 | 1439 | Pfam | Protein tyrosine and serine/threonine kinase | 1154 | 1410 | IPR001245 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | MobiDBLite | consensus disorder prediction | 1416 | 1439 | - | - | |
Vra5g0402 | 1439 | SMART | PB1_new | 230 | 317 | IPR000270 | GO:0005515 | |
Vra5g0402 | 1439 | ProSitePatterns | Serine/Threonine protein kinases active-site signature. | 1274 | 1286 | IPR008271 | GO:0004672|GO:0006468 | |
Vra5g0402 | 1439 | CDD | PB1_UP2 | 219 | 316 | - | - | |
Vra5g0402 | 1439 | CDD | STKc_MAP3K-like | 1155 | 1410 | - | - | |
Vra5g0402 | 1439 | SMART | serkin_6 | 1149 | 1420 | IPR000719 | GO:0004672|GO:0005524|GO:0006468 |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Vra5g0402 | Vra-Chr5 | 4171133 | 4178897 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Vra5g0402 | 214 | 694 | MAP Kinase Kinase Kinase | AT3G46920 | 39.344 | 1.53e-81 | 291 |
Select | Regulatory Factors | Family | Gene | Hmm_acc | Hmm_name | E_value | Clan |
---|---|---|---|---|---|---|---|
PK | TKL-Pl-6 | Vra5g0402 | PK_Tyr_Ser-Thr | 5.5e-59 | CL0016 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Vra5g0402 | - | - | pvu:PHAVU_009G209700g | 2472.2 |